newsfilter
← Latest News
PR Newswire·

Generate Biomedicines, Inc. Announces Pricing of Initial Public Offering

Generate Biomedicines, Inc. (Nasdaq: GENB) ("Generate"), a clinical-stage generative biology company pioneering the AI revolution in biotechnology...